IVD Research, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

IVD Research, Inc. - overview

Established

1996

Location

Carlsbad, CA, US

Primary Industry

Medical Devices & Equipment

About

IVD Research, Inc. is a US-based company focused on developing and manufacturing diagnostic assays, offering innovative solutions for pathogen detection in clinical and laboratory environments. Founded in 1996, IVD Research, Inc. is privately held by Dave Lambillotte, Ann Marie Martin and Christopher Lambillotte which specializes in diagnostic assay development and contract manufacturing services.


The company is headquartered in Carlsbad, US. In December 2025, IVD Research, Inc. was acquired by KVP International, Inc. , a portfolio company of Carmelina Capital Partners, allowing for an expansion in research and development resources.


IVD Research, Inc. specializes in developing and manufacturing diagnostic assays and contract manufacturing services, particularly high-performance detection assays for global pathogens. Their product range includes ELISA (Enzyme-Linked Immunosorbent Assay), DFA (Direct Fluorescent Antibody) tests, and Lateral Flow Test Kits, which are used in various clinical and laboratory settings for diagnosing infectious diseases. IVD Research caters to a diverse client base including biotech companies, laboratories, and healthcare institutions, primarily in North America and Europe, emphasizing custom solutions to meet specific client needs while ensuring quality and innovation in diagnostics.


IVD Research generates revenue through its contract manufacturing services and sales of diagnostic products, operating mainly on a business-to-business model. Partnerships or contracts define client engagements, focusing on assay development or manufacturing processes structured around project-based agreements. The company offers a variety of products and services, including custom contract manufacturing packages, which involve phased development from research and development to full commercialization, with transactions structured around bulk orders or long-term supply agreements for diagnostic kits. Looking ahead, IVD Research, Inc.


aims to enhance its product portfolio with new diagnostic assays designed for emerging pathogens, targeting product launches in 2026. Following its acquisition by KVP International, IVD Research plans to expand its diagnostic portfolio and manufacturing capacity. The focus will be on leveraging KVP’s global distribution channels and investing in advanced technologies for rapid point-of-care testing.


Current Investors

KVP International, Inc.

Primary Industry

Medical Devices & Equipment

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment

Website

www.ivdresearch.com/

Verticals

Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

IVD Research, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedIVD Research, Inc.-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.